Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.470
0.00 (0.00%)
At close: Sep 18, 2025, 4:00 PM EDT
1.520
+0.050 (3.40%)
After-hours: Sep 18, 2025, 7:58 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $129.69 million as of September 18, 2025. Its market cap has increased by 354.24% in one year.
Market Cap
129.69M
Enterprise Value
119.41M
1-Year Change
354.24%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $129.69M, a decrease of -49.43%. That is a compound annual growth rate of -15.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 129.69M | 345.09% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |